- Q1 2024 Revolution Medicines Inc Earnings Call TranscriptMay 08, 2024$38.31 (-1.47%)Earnings
- Q4 2023 Revolution Medicines Inc Earnings Call TranscriptFeb 26, 2024$30.38 (+2.15%)Earnings
- Revolution Medicines Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Revolution Medicines Inc Earnings Call TranscriptNov 06, 2023$21.54 (-2.80%)Earnings
- Revolution Medicines Inc To Discuss ESMO Data Presentation Call TranscriptOct 22, 2023
- Q2 2023 Revolution Medicines Inc Earnings Call TranscriptAug 08, 2023$30.17 (+1.79%)Earnings
- Revolution Medicines Inc To Acquire EQRx Inc Call TranscriptAug 01, 2023
- Revolution Medicines Inc at Barclays Lunchtime Biotech Fireside Chat Series TranscriptJun 15, 2023
- Revolution Medicines Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Revolution Medicines Inc Earnings Call TranscriptMay 08, 2023$24.44 (+0.41%)Earnings
- Revolution Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Q4 2022 Revolution Medicines Inc Earnings Call TranscriptFeb 27, 2023$24.37 (+0.16%)Earnings
- Revolution Medicines Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Revolution Medicines Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Revolution Medicines Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Q2 2022 Revolution Medicines Inc Earnings Call TranscriptAug 09, 2022$23.76 (-2.62%)Earnings
- Revolution Medicines Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Revolution Medicines Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Q2 2021 Revolution Medicines Inc Earnings Call TranscriptAug 11, 2021$26.9 (-0.81%)Earnings
- Revolution Medicines Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Revolution Medicines Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Revolution Medicines Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Q2 2022 Revolution Medicines Inc Earnings Call Transcript
Good day, my name is Christy, and I will be your conference facilitator today. Welcome to the Revolution Medicines' second-quarter 2022 earnings conference call. Today's call is being recorded. (Operator Instructions)
I would now like to hand the conference over to David Arrington, Revolution Medicines' SVP of Investor Relations & Corporate Affairs for opening remarks. David, you may begin.
Thank you, and welcome, everyone, to our second-quarter earnings call. Joining me on today's call are Dr. Mark Goldsmith, Revolution Medicines' Chairman and Chief Executive Officer; Dr. Steve Kelsey, the company's President, Research and Development; and Jack Anders, our SVP of Finance and Principal Accounting Officer.
As we begin, I would like to note that our presentation will include statements regarding the current beliefs of the company with respect to our business that constitute forward-looking statements within the meaning of the Private Securities
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)